BioRx Creates FULL CIRCLE™ Program in Support of The Immune Deficiency Foundation
CINCINNATI — BioRx, one of the nation’s fastest growing providers of specialty pharmaceuticals, announces the creation of a new program to help patients with primary immunodeficiency diseases (PIDD). Their program, called Full Circle™, has been established to provide financial support to the Immune Deficiency Foundation (IDF), the national patient organization with the mission to improve the diagnosis and treatment of patients with primary immune deficiency diseases through research, education and advocacy.
As the first “Sponsor” of IDF’s new Home Healthcare and Specialty Pharmacy Sponsorship program, BioRx has committed to making a base level contribution to the IDF annually. Additionally, BioRx will contribute $1 for every gram of IVIG (intravenous immunoglobulin) or SCIG (subcutaneous immunoglobulin) that the company dispenses to any patient, who is being treated for a primary immunodeficiency.
“We believe in the work that the IDF is doing and feel it is our obligation and privilege to support the PIDD community through their organization,” says Eric Hill, Vice President and co-founder of BioRx. “We hope that this commitment will help enhance the early diagnosis of primary immunodeficiency diseases, improve access to state of the art medical care, and expand scientific and medical research on such diseases.”
According to Marcia Boyle, President and Founder of IDF, “As a patient focused organization, IDF applauds the commitment that BioRx is making to our mission on behalf of patients with primary immunodeficiency diseases. We are excited about this new initiative and thankful for their support and recognition of the importance of our work. As the first company to participate in our Home Healthcare and Specialty Pharmacy Sponsorship Program and their ongoing pledge to support IDF, BioRx has shown a corporate commitment to the PIDD community.”
More information about BioRx’s Full Circle™ program is available by calling 866.44.BIORX or via email at email@example.com. Information may also be requested through the company’s website at www.biorx.net.
About The Immune Deficiency Foundation
The Immune Deficiency Foundation (IDF), founded in 1980, is the national non-profit patient organization dedicated to improving the diagnosis and treatment of patients with primary immunodeficiency diseases through research, education, and advocacy.
There are over 130 different primary immunodeficiency diseases and they affect approximately 250,000 people in the United States. These individuals live throughout the country and often find it difficult to receive specialized health care, and proper diagnosis and treatment. Individuals affected by primary immunodeficiency diseases also experience difficulties financing their health care, finding educational materials on the disease, and locating others with whom to share their experiences. The goal of IDF is to help individuals overcome these difficulties and live a healthy and productive life. To learn more about IDF visit www.primaryimmune.org.
Based in Cincinnati, BioRx is a national pharmacy specializing in highly customized care for the primary immunodeficiency diseases (PIDD) community. As one of the nation’s fastest growing providers of IgG and other specialty pharmaceuticals the company’s clinical staff reaches patients and physicians in 48 states. To learn more about BioRx visit www.biorx.net.